Literature DB >> 12704151

Inhibition of gamma interferon decreases bacterial load in peritonitis by accelerating peritoneal fibrin deposition and tissue repair.

Gang Qiu1, Elizabeth Gribbin, Kathryn Harrison, Neil Sinha, Kingsley Yin.   

Abstract

Bowel perforation can lead to significant bacterial spillage, which may then cause septic peritonitis, characterized by a systemic inflammatory response and organ dysfunction. There are several reports that have shown that the development of peritoneal adhesions is dependent on inflammatory cytokine levels and that these adhesions can reduce bacterial spread, possibly by sealing off the cecum in the cecal ligation and puncture (CLP) model of septic peritonitis. There have not, however, been any studies that have utilized a strategy to accelerate tissue repair in order to seal off the injured cecum and reduce bacterial spread as well as ameliorate systemic inflammation. In the present study, we demonstrate that the administration of anti-gamma interferon (IFN-gamma) antibody (1.2 mg/kg of body weight, intravenously) accelerated tissue repair via increased fibrin deposition 12 and 24 h after CLP in rats. This increase in fibrin deposition was associated with peritoneal adhesion 24 h after CLP and a reduction in bacterial load compared to the bacterial load of rats given irrelevant antibody. Plasma fibrin levels, however, were not altered after IFN-gamma antibody administration, suggesting that the inhibition of IFN-gamma activity specifically increased fibrin deposition to the site of injury. Furthermore, plasma interleukin-6, used as a marker of systemic inflammatory response, was reduced in CLP rats given IFN-gamma antibody compared to that found in those given irrelevant antibody. These results suggest that the early inhibition of IFN-gamma activity in the CLP model is beneficial by accelerating fibrin deposition in cecal tissue to prevent bacterial spread and reduce the systemic inflammatory response. Importantly, increased fibrin deposition in the ceca was not associated with increased plasma fibrin whereas the latter may have detrimental effects associated with coagulation disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704151      PMCID: PMC153258          DOI: 10.1128/IAI.71.5.2766-2774.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Multiple roles for IL-12 in a model of acute septic peritonitis.

Authors:  M L Steinhauser; C M Hogaboam; N W Lukacs; R M Strieter; S L Kunkel
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  The pulmonary inflammatory response to experimental fecal peritonitis: relative roles of tumor necrosis factor-alpha and endotoxin.

Authors:  M A Mercer-Jones; M Heinzelmann; J C Peyton; D J Wickel; M Cook; W G Cheadle
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

3.  Monocyte deactivation in septic patients: restoration by IFN-gamma treatment.

Authors:  W D Döcke; F Randow; U Syrbe; D Krausch; K Asadullah; P Reinke; H D Volk; W Kox
Journal:  Nat Med       Date:  1997-06       Impact factor: 53.440

4.  Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis.

Authors:  N Zantl; A Uebe; B Neumann; H Wagner; J R Siewert; B Holzmann; C D Heidecke; K Pfeffer
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Immunopathologic responses to non-lethal sepsis.

Authors:  S J Ebong; D R Call; G Bolgos; D E Newcomb; J I Granger; M O'Reilly; D G Remick
Journal:  Shock       Date:  1999-08       Impact factor: 3.454

Review 6.  Use of fibrinolytic agents in the prevention of postoperative adhesion formation.

Authors:  B W Hellebrekers; T C Trimbos-Kemper; J B Trimbos; J J Emeis; T Kooistra
Journal:  Fertil Steril       Date:  2000-08       Impact factor: 7.329

7.  Peritoneal fluid cytokine and eicosanoid levels and their relation to the incidence of peritoneal adhesion.

Authors:  N Chegini; H Rong; B Bennett; I K Stone
Journal:  J Soc Gynecol Investig       Date:  1999 May-Jun

8.  Role of a hyaluronate-based membrane in the prevention of peritonitis-induced adhesions.

Authors:  A M Ghellai; A F Stucchi; D J Lynch; K C Skinner; M J Colt; J M Becker
Journal:  J Gastrointest Surg       Date:  2000 May-Jun       Impact factor: 3.452

9.  Role of liver NK cells and peritoneal macrophages in gamma interferon and interleukin-10 production in experimental bacterial peritonitis in mice.

Authors:  S Seki; S Osada; S Ono; S Aosasa; Y Habu; T Nishikage; H Mochizuki; H Hiraide
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

Review 10.  Tumor necrosis factor in the heart.

Authors:  D R Meldrum
Journal:  Am J Physiol       Date:  1998-03
View more
  7 in total

1.  In situ assays demonstrate that interferon-gamma suppresses infection-stimulated hepatic fibrin deposition by promoting fibrinolysis.

Authors:  I K Mullarky; F M Szaba; C G Winchel; M A Parent; L W Kummer; N Mackman; L L Johnson; S T Smiley
Journal:  J Thromb Haemost       Date:  2006-07       Impact factor: 5.824

2.  Calcium-dependent phospholipase A2 modulates infection-induced diaphragm dysfunction.

Authors:  Gerald S Supinski; Alexander P Alimov; Lin Wang; Xiao-Hong Song; Leigh A Callahan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-03-11       Impact factor: 5.464

3.  Tumor necrosis factor alpha and gamma interferon, but not hemorrhage or pathogen burden, dictate levels of protective fibrin deposition during infection.

Authors:  Isis K Mullarky; Frank M Szaba; Kiera N Berggren; Lawrence W Kummer; Lindsey B Wilhelm; Michelle A Parent; Lawrence L Johnson; Stephen T Smiley
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

4.  Gammadelta T cells mitigate the organ injury and mortality of sepsis.

Authors:  Johannes Tschöp; André Martignoni; Holly S Goetzman; Lisa G Choi; Quan Wang; John G Noel; Cora K Ogle; Timothy A Pritts; Jay A Johannigman; Alex B Lentsch; Charles C Caldwell
Journal:  J Leukoc Biol       Date:  2007-12-06       Impact factor: 4.962

5.  Resveratrol attenuates TLR-4 mediated inflammation and elicits therapeutic potential in models of sepsis.

Authors:  Binbin Wang; Gregory Lucien Bellot; Kartini Iskandar; Tsung Wen Chong; Fera Yiqian Goh; June Jingyi Tai; Herbert Schwarz; Siew Cheng Wong; Shazib Pervaiz
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

6.  Novel Predictors and Risk Score of Treatment Failure in Peritoneal Dialysis-Related Peritonitis.

Authors:  Xiang Liu; Aiya Qin; Huan Zhou; Xueqin He; Shamlin Cader; Sirui Wang; Yi Tang; Wei Qin
Journal:  Front Med (Lausanne)       Date:  2021-03-19

7.  Sepsis mediators.

Authors:  François Philippart; Jean-Marc Cavaillon
Journal:  Curr Infect Dis Rep       Date:  2007-09       Impact factor: 3.725

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.